the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

PM Anwar urges caution on calls for Malaysia’s withdrawal from US-led maritime exercise

LABUAN: Malaysia must adopt a rational approach in responding to the calls from non-governmental organisations (NGOs) to withdraw from a US-led maritime military exercise that includes the participation of the Israeli army.

Prime Minister Datuk Seri Anwar Ibrahim emphasised the need for thorough consideration of the matter and its potential implications.

“Our stance is firm; no country is as vocal as Malaysia on the Israel issue…we protest every day.

“We must act carefully and not be driven by anger sentiments…even during the previous Perikatan (Nasional) government, an Israeli ship docked at our port.

“When we took over the government, we were the ones who stopped the Israeli ship from anchoring, despite facing criticism,” Anwar told reporters after visiting the Labuan Roll-on Roll-off Ferry Terminal here today.

Anwar stressed the government’s actions should not compromise the interests of the people and trade.

“If we were to follow the suggested approaches, we would need to halt the operations of companies like Microsoft, Google, Apple and Facebook,” he said.

“Malaysia will continue to voice out against the cruelty faced by the Palestinian people,” he added.

On May 30, 15 groups led by the Malaysian chapter of the global anti-Israel movement Boycott, Divestment, Sanctions (BDS Malaysia) issued a joint statement demanding Malaysia’s immediate withdrawal from the Rim of the Pacific Exercise (Rimpac), scheduled to take place from June 26 to Aug 2.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings